MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
985.68M
P/E Ratio
N/A
Total Cash
451.58M
Projected Growth
N/A
Total Debt
2.89M
Revenue
133.67M
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
4.40
Total Debt/Equity
N/A
Revenue/Share
1.30 USD as % of share price

Fundamentals

DAWN
Capitalization
986M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
452M
Total Cash/Share
4.40
Total Debt
2.89M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.30%
Revenue
134M
ROE
N/A
Book Value
451M
P/B Ratio
2.19
Cash Flow
N/A
Earnings
-1.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
8.68
Current Revenue Per Employee
219861.88
Dividends Per Share - Security
N/A
EBITDA
-162.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.74
Revenue To Assets
-27.23
Shares Held By Institutions
895M
Shares Outstanding - Current
103M
Total Liabilities
62.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-24.230
View a ticker or compare two or three
DAWN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com